Gossamer Bio Statistics
Total Valuation
Gossamer Bio has a market cap or net worth of $157.63 million. The enterprise value is $34.22 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Gossamer Bio has 226.60 million shares outstanding. The number of shares has increased by 88.97% in one year.
Current Share Class | 226.60M |
Shares Outstanding | 226.60M |
Shares Change (YoY) | +88.97% |
Shares Change (QoQ) | -5.11% |
Owned by Insiders (%) | 3.17% |
Owned by Institutions (%) | 63.71% |
Float | 188.05M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.49 |
Forward PS | n/a |
PB Ratio | 2.91 |
P/TBV Ratio | 2.91 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.32 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.74, with a Debt / Equity ratio of 3.76.
Current Ratio | 6.74 |
Quick Ratio | 6.53 |
Debt / Equity | 3.76 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -5.23 |
Financial Efficiency
Return on equity (ROE) is -90.26% and return on invested capital (ROIC) is -13.58%.
Return on Equity (ROE) | -90.26% |
Return on Assets (ROA) | -11.24% |
Return on Capital (ROIC) | -13.58% |
Revenue Per Employee | $780,163 |
Profits Per Employee | -$530,719 |
Employee Count | 135 |
Asset Turnover | 0.30 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Gossamer Bio has paid $3.30 million in taxes.
Income Tax | 3.30M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.41% in the last 52 weeks. The beta is 1.96, so Gossamer Bio's price volatility has been higher than the market average.
Beta (5Y) | 1.96 |
52-Week Price Change | -8.41% |
50-Day Moving Average | 0.91 |
200-Day Moving Average | 0.93 |
Relative Strength Index (RSI) | 25.98 |
Average Volume (20 Days) | 966,815 |
Short Selling Information
The latest short interest is 6.30 million, so 2.78% of the outstanding shares have been sold short.
Short Interest | 6.30M |
Short Previous Month | 6.95M |
Short % of Shares Out | 2.78% |
Short % of Float | 3.35% |
Short Ratio (days to cover) | 8.17 |
Income Statement
In the last 12 months, Gossamer Bio had revenue of $105.32 million and -$71.65 million in losses. Loss per share was -$0.32.
Revenue | 105.32M |
Gross Profit | 105.32M |
Operating Income | -62.82M |
Pretax Income | -172.58M |
Net Income | -71.65M |
EBITDA | -61.80M |
EBIT | -62.82M |
Loss Per Share | -$0.32 |
Full Income Statement Balance Sheet
The company has $327.03 million in cash and $203.63 million in debt, giving a net cash position of $123.41 million or $0.54 per share.
Cash & Cash Equivalents | 327.03M |
Total Debt | 203.63M |
Net Cash | 123.41M |
Net Cash Per Share | $0.54 |
Equity (Book Value) | 54.14M |
Book Value Per Share | 0.24 |
Working Capital | 293.18M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -1.41M |
Capital Expenditures | n/a |
Free Cash Flow | -1.41M |
FCF Per Share | -$0.01 |
Full Cash Flow Statement Margins
Gross margin is 100.00%, with operating and profit margins of -59.64% and -68.03%.
Gross Margin | 100.00% |
Operating Margin | -59.64% |
Pretax Margin | -64.89% |
Profit Margin | -68.03% |
EBITDA Margin | -58.68% |
EBIT Margin | -59.64% |
FCF Margin | n/a |
Dividends & Yields
Gossamer Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -88.97% |
Shareholder Yield | -88.97% |
Earnings Yield | -45.45% |
FCF Yield | -0.90% |
Analyst Forecast
The average price target for Gossamer Bio is $9.20, which is 1,222.60% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $9.20 |
Price Target Difference | 1,222.60% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Gossamer Bio has an Altman Z-Score of -3.81 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.81 |
Piotroski F-Score | 2 |